Minimally invasive surgery for cancer of the oesophagus

Prof Christophe Mariette - Hospital Center Regional University De Lille, Lille, France
Minimally invasive surgery for cancer of the oesophagus ( Prof Christophe Mariette - Hospital Center Regional University De Lille, Lille, France )
5 Jul 2017

Acquired resistance to EGFR antibodies

Dr Federica Di Nicolantonio - Candiolo Cancer Institute, Turin, Italy
Acquired resistance to EGFR antibodies ( Dr Federica Di Nicolantonio - Candiolo Cancer Institute, Turin, Italy )
5 Jul 2017

WIN 2017 conference review

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
WIN 2017 conference review ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
5 Jul 2017

Working With Cancer: helping people affected by cancer return to work

Mandy Goodman and Barbara Wilson - Working With Cancer
Working With Cancer: helping people affected by cancer return to work ( Mandy Goodman and Barbara Wilson - Working With Cancer )
14 Jun 2017

Gastrectomy and oral drug prescription

Prof Alain Astier – Universidad de Paris, Paris, France
Gastrectomy and oral drug prescription ( Prof Alain Astier – Universidad de Paris, Paris, France )
14 Jun 2017

Improving care for cancer patients

Dr David Hui - MD Anderson Cancer Center, Houston, USA
Improving care for cancer patients ( Dr David Hui - MD Anderson Cancer Center, Houston, USA )
14 Jun 2017

Managing cancer and living meaningfully

Dr Gary M. Rodin - UHN Princess Margaret Hospital, Toronto, Canada
Managing cancer and living meaningfully ( Dr Gary M. Rodin - UHN Princess Margaret Hospital, Toronto, Canada )
14 Jun 2017

3 or 6 months adjuvant oxaliplatin for colorectal cancer

Dr Tim Iveson - University Hospital Southampton, Salisbury, UK
3 or 6 months adjuvant oxaliplatin for colorectal cancer ( Dr Tim Iveson - University Hospital Southampton, Salisbury, UK )
4 Jun 2017

Discovering genes in mammary cancer by insertional mutagenesis

Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands
Discovering genes in mammary cancer by insertional mutagenesis ( Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands )
27 Apr 2017

Treatment choices for HER2 amplified colorectal cancer

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Treatment choices for HER2 amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017

Final results of the HERACLES trial in HER2-amplified colorectal cancer

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Final results of the HERACLES trial in HER2-amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017